Omnicare, Inc. (OCR) Tops Q1 EPS by 1c

Omnicare, Inc. (NYSE: OCR) reported Q1 EPS of $0.91, $0.01 better than the analyst estimate of $0.90. Revenue for the quarter came in at $1.57 billion versus the consensus estimate of $1.55 billion.

Omnicare concluded the first-quarter of 2014 with no borrowings outstanding on its revolving credit facility, other than approximately $14 million in standby letters of credit, and $347 million in cash on its balance sheet.

In the first quarter, Omnicare repurchased 1.6 million shares for an aggregate amount of $95 million. As of March 31, 2014, the Company had approximately $405 million of availability under its current share repurchase authorization.

Omnicare, Inc. reaffirmed FY2014 guidance.

For earnings history and earnings-related data on Omnicare, Inc. (OCR) click here.

You May Also Be Interested In

• Biogen (BIIB) tops earnings expectations but revenue falls short
• Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
• Canadian Pacific Kansas City (CP) Tops Q1 EPS by 93c